The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for ...

Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...

Novartis has reached a deal to buy Myricx Bio for up to $1.5 billion, giving it control of the London, UK, start-up's ...

Sir Chris Hoy has said he feels "very proud" when he hears of people taking part in the charity cycling event he set up last ...

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

The FDA has started a priority review of BeOne Medicines' BCL2 inhibitor sonrotoclax in relapsed or refractory mantle cell lymphoma (MCL), setting up a decision on US approval next year. Sonrotoclax ...

The Alzheimer's Association has pushed back against comments by Health and Human Services (HHS) Secretary Robert F Kennedy Jr about research into the disease that it has labelled "inaccurate and ...

Roche has posted a mixed set of data from two clinical trials of its anti-IL-33/ST2 antibody astegolimab in chronic obstructive pulmonary disease (COPD), casting a shadow over the programme. On the ...

A series of pilot schemes set up by the UK in partnership with the pharma industry will test ways to get new medicines to ...

Bill Gates has made a $50 million donation to the Dementia Discovery Fund, a collaboration between pharma, the UK government and the charity Alzheimer’s Research UK, that aims to challenge the ...

Zealand Pharma's CEO, Adam Steensberg. Shares in Zealand Pharma lost around a third of their value today, after it reported phase 2 data with Roche-partnered weight-loss therapy petrelintide. The sell ...

Two top healthcare investors – UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category with $21 billion in assets under management. The combined ...